Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 69

Adult ID

Global ID

Investigative ID

Trainee
Symposium

53 - Clinical Controversies in S. aureus Bacteremia

Thursday, September 30, 2021
5:15 PM - 6:30 PM EDT

    Moderator(s)

  • Amanda Schnee, MD

    Clinical Assistant Professor
    Prisma Health
    Greenville, SC, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Thomas Holland, MD

    Associate Professor, Department of Medicine, Division of Infectious Diseases
    Duke University
    Raleigh, NC, United States

    Aridis (Individual(s) Involved: Self): Consultant; Basilea Pharmaceutica (Individual(s) Involved: Self): blinded adjudication, Consultant, Other Financial or Material Support; Genentech (Individual(s) Involved: Self): Consultant; Lysovant (Individual(s) Involved: Self): Consultant; Motif Bio (Individual(s) Involved: Self): Consultant

    • Speaker(s)

  • Amit Pai, PharmD

    Professor and Chair
    University of Michigan, MI, United States

    Paratek (Individual(s) Involved: Self): Consultant; Wolters-Kluwer (Individual(s) Involved: Self): Advisor or Review Panel member

  • TL

    Todd Lee, MD, MPH

    Associate Professor of Medicine
    Medicine
    McGill University
    Montreal, Quebec, Canada

    Antibiotic Sentinel Corporation (Individual(s) Involved: Self): Copyright-Antibiogram software, Other Financial or Material Support; MedSafer Corporation (Individual(s) Involved: Self): Copyright-Deprescribing software for elderly, Other Financial or Material Support

  • M. Rizwan Sohail, MD

    Professor of Medicine
    Baylor College of Medicine
    Sugarland, TX, United States

    Aziyo Biologics (Individual(s) Involved: Self): Consultant; Philips (Individual(s) Involved: Self): Consultant

Participants should be aware of the following financial/non-financial relationships:
Amanda Schnee, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thomas L. Holland, MD: Aridis (Individual(s) Involved: Self): Consultant; Basilea Pharmaceutica (Individual(s) Involved: Self): blinded adjudication, Consultant, Other Financial or Material Support; Genentech (Individual(s) Involved: Self): Consultant; Lysovant (Individual(s) Involved: Self): Consultant; Motif Bio (Individual(s) Involved: Self): Consultant
Amit Pai, PharmD: Paratek (Individual(s) Involved: Self): Consultant; Wolters-Kluwer (Individual(s) Involved: Self): Advisor or Review Panel member
Todd C. Lee, MD, MPH: Antibiotic Sentinel Corporation (Individual(s) Involved: Self): Copyright-Antibiogram software, Other Financial or Material Support; MedSafer Corporation (Individual(s) Involved: Self): Copyright-Deprescribing software for elderly, Other Financial or Material Support
M. Rizwan Sohail, MD: Aziyo Biologics (Individual(s) Involved: Self): Consultant; Philips (Individual(s) Involved: Self): Consultant

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • explain how to evaluate S. aureus bacteremia patients for endocarditis
  • analyze the antibiotic options for MRSA bacteremia
  • select optimal antibiotic doses for S aureus bacteremia in special populations

Presentations:

  • Optimal Dosing of Antibiotics for S. aureus Bacteremia in Specific Populations

    Speaker: Amit Pai, PharmD – University of Michigan

  • Treatment Approach for S. aureus Bacteremia

    Speaker: Todd C. Lee, MD, MPH – McGill University

  • Updates in SAB Diagnosis and Prognosis

    Speaker: M. Rizwan Sohail, MD – Baylor College of Medicine